Clinical trial
Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers
NCT04281758 is registered in ClinicalTrials.gov with PepsiCo Global R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers
- Lead sponsor
- PepsiCo Global R&D
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 20, 2020
- Completion date
- October 13, 2020
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
plasma caffeine concentration